2021 · Growth Investment
KKR investment in Sapphiros
Sapphiros is a newly formed platform created in partnership with Namal Nawana - an experienced medical device executive and the former CEO of both Smith & Nephew and Alere - to acquire and operate a portfolio of next-generation diagnostic technologies with strong growth potential
Research completeness
A completeness measure, not an investment score. Core coverage measures identity, ownership, chronology, classification, company facts, sources and review status. Transaction announcements can also earn depth from disclosed people, providers, value, completion evidence and structured findings.
Transaction facts
- Investment year
- 2021
- Evidence level
- Official Portfolio Record
- Status
- Completed
- Transaction type
- Growth Investment
- Seller
- Not established
Publicly disclosed provider roles
No provider role has been added from the reviewed public sources.
Named transaction professionals
No individual transaction attribution has been added from the reviewed public sources.